{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T19:41:27Z","timestamp":1775590887451,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1007\/s10637-005-1441-3","type":"journal-article","created":{"date-parts":[[2005,7,12]],"date-time":"2005-07-12T18:00:00Z","timestamp":1121191200000},"page":"331-337","source":"Crossref","is-referenced-by-count":34,"title":["Phase I\/II study of amrubicin, a novel 9-aminoanthracycline, in patients with advanced non-small-cell lung cancer"],"prefix":"10.1007","volume":"23","author":[{"given":"Takahiko","family":"Sugiura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Ariyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Negoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harumichi","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Fukuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1441_CR1","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1021\/jo00229a010","volume":"52","author":"K Ishizumi","year":"1987","unstructured":"Ishizumi K, Ohashi N, Tanno N: Stereospecific total synthesis of 9-aminoanthracyclines: (+)-9-amino-9-deoxydaunomycin and related compounds. J Org Chem 52: 4477\u20134485, 1987","journal-title":"J Org Chem"},{"key":"1441_CR2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1349-7006.1989.tb02247.x","volume":"80","author":"S Morisada","year":"1989","unstructured":"Morisada S, Yanagi Y, Noguchi T, Kashiwazaki Y, Fukui M: Antitumor activities of a novel 9-aminoanthracycline (SM-5887) against mouse experimental tumors and human tumor xenografts. Jpn J Cancer Res 80: 69\u201376, 1989","journal-title":"Jpn J Cancer Res"},{"key":"1441_CR3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1349-7006.1989.tb02248.x","volume":"80","author":"S Morisada","year":"1989","unstructured":"Morisada S, Yanagi Y, Kashiwazaki Y, Fukui M: Toxicological aspects of a novel 9-aminoanthracyline, SM-5887. Jpn J Cancer Res 80: 77\u201382, 1989","journal-title":"Jpn J Cancer Res"},{"key":"1441_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1023\/A:1005862730941","volume":"15","author":"T Suzuki","year":"1997","unstructured":"Suzuki T, Minamida S, Iwasaki T, Yamamoto H, Kanda H: Cardiotoxicity of a new anthracycline derivative (SM-5887) following intravenous administration to rabbits: Comparative study with doxorubicin. Invest New Drugs 15: 219\u2013225, 1997","journal-title":"Invest New Drugs"},{"key":"1441_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1023\/A:1006088907271","volume":"16","author":"T Noda","year":"1998","unstructured":"Noda T, Watanabe T, Kohda A, Hosokawa S, Suzuki T: Chronic effects of a novel synthetic anthracycline derivative (SM-5887) on normal heart and doxorubicin-induced cardiomyopathy in dogs. Invest New Drugs 16: 121\u2013128, 1998","journal-title":"Invest New Drugs"},{"key":"1441_CR6","unstructured":"Hiraki S, Shinkai T, Furuse K, Fukuoka M, Ohnoshi T, Kimura I, The SM-5887 lung cancer study group: A phase II study of SM-5887, a novel 9-aminoanthracycline, for non-small-cell lung cancer. Proceedings of the 18th International Congress of Chemotherapy 866\u2013867, 1993"},{"key":"1441_CR7","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1349-7006.1998.tb00498.x","volume":"89","author":"T Yamaoka","year":"1998","unstructured":"Yamaoka T, Hanada M, Ichii S, Morisada S, Noguchi T, Yanagi Y: Cytotoxicity of amrubicin, a novel 9-aminoanthracycline, and its active metabolite amrubicinol on human tumor cells. Jpn J Cancer Res 89: 1067\u20131073, 1998","journal-title":"Jpn J Cancer Res"},{"key":"1441_CR8","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1349-7006.1998.tb00496.x","volume":"89","author":"T Noguchi","year":"1998","unstructured":"Noguchi T, Ichii S, Morisada S, Yamaoka T, Yanagi Y: In vivo efficacy and tumor-selective metabolism of amrubicin to its active metabolite. Jpn J Cancer Res 89: 1055\u20131060, 1998","journal-title":"Jpn J Cancer Res"},{"key":"1441_CR9","unstructured":"Noguchi T, Ichii S, Morisada S, Yamaoka T, Yanagi Y: Evaluation of amrubicin with a 5 day administration schedule in a mouse model. Jpn J Cancer Res 26: 1305\u20131312."},{"key":"1441_CR10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1200\/JCO.1992.10.2.297","volume":"10","author":"R Feld","year":"1992","unstructured":"Feld R, Wierzbicki R, Walde PL, Shepherd FA, Gupta S, Shannon P, Lassus M: Phase I-II study of high-dose epirubicin in advanced non-small-cell lung cancer. J Clin Oncol 10: 297\u2013303, 1992.","journal-title":"J Clin Oncol"},{"key":"1441_CR11","first-page":"101","volume":"28","author":"Japan Society for Cancer Therapy","year":"1993","unstructured":"Japan Society for Cancer Therapy: Criteria for the evaluation of the clinical effects of solid cancer chemotherapy. J Jpn Soc Cancer Ther 28: 101\u2013130, 1993.","journal-title":"J Jpn Soc Cancer Ther"},{"key":"1441_CR12","unstructured":"World Health Organization: Handbook for Reporting Results of Cancer Treatment (WHO Offst Publication No. 48). Geneva, Switzerland, World Health Organization, 1979."},{"key":"1441_CR13","unstructured":"Ginsberg RJ, Vokes EE, Raben A: Non-small cell lung cancer. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, 5th ed. New York, NY, 1997: 858\u2013911."},{"key":"1441_CR14","first-page":"1087","volume":"5","author":"PA Bunn","year":"1998","unstructured":"Bunn PA, Kelly K: New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: A review of the literature and future directions. Clin Cancer Res 5: 1087\u20131100, 1998","journal-title":"Clin Cancer Res"},{"key":"1441_CR15","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1349-7006.1998.tb00519.x","volume":"89","author":"M Hanada","year":"1998","unstructured":"Hanada M, Mizuno S, Fukushima A, Saito Y, Noguchi T, Yamaoka T: A new antitumor agent amrubicin induces cell growth inhibition by stabilizing topoisomerase II-DNA complex. Jpn J Cancer Res 89: 1229\u20131238, 1998","journal-title":"Jpn J Cancer Res"},{"key":"1441_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF00170860","volume":"7","author":"K Inoue","year":"1989","unstructured":"Inoue K, Ogawa M, Horikoshi N, Mukaiyama T, Itoh Y, Imajoh K, Ozeki H, Nagamine D, Shinagawa K: Phase I and pharmacokinetic study of SM-5887, a new anthracycline derivative. Invest New Drugs 7: 213\u2013218, 1989","journal-title":"Invest New Drugs"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-005-1441-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-005-1441-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-005-1441-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-005-1441-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T17:59:45Z","timestamp":1678557585000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-005-1441-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["1441"],"URL":"https:\/\/doi.org\/10.1007\/s10637-005-1441-3","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}